News & Perspective

Jul 26, 2017

Jul 26, 2017

Stewardship / Resistance Scan for Jul 26, 2017

New antibiotics class
Triple-drug combo for MCR-1 & NDM-5
US MRSA trends

Aug 30, 2010

Aug 30, 2010

HHS funds development of drug for plague, tularemia

(CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded a contract to a San Francisco company to further the development of a new broad-spectrum antibiotic for treating plague, tularemia, and various resistant infections.